Our medical consultants reviewed a case of a 63-year-old male who received several doses of Factor VII during a prolonged inpatient stay. The patient had a diagnosis of prostate cancer was suffering from excessive blood in the urine. The billed charges for the Factor VII were $450,000. AMS consultants reviewed the case and determined that the patient did not have a Factor VII deficiency and that its administration was not medically necessary for the patient’s diagnosis. The review done by our medical experts resulted in $450,000 in claims cost savings for the client.

Back To Case Studies